Hidetomo Himuro

616 total citations
19 papers, 390 citations indexed

About

Hidetomo Himuro is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hidetomo Himuro has authored 19 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hidetomo Himuro's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Hidetomo Himuro is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Hidetomo Himuro collaborates with scholars based in Japan and United States. Hidetomo Himuro's co-authors include Atsushi Mizoguchi, Emiko Mizoguchi, Tetsuro Sasada, Taku Kouro, Toshiyuki Okada, Yuka Igarashi, Koichi Azuma, Feifei Wei, Norikazu Matsuo and Haruhiro Saito and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and The Journal of Pathology.

In The Last Decade

Hidetomo Himuro

16 papers receiving 380 citations

Peers

Hidetomo Himuro

IMMUN

ONCOL

GENET

SURGE

Daisuke Koyama Japan

Xiaoping Lv China

Amanda Thomson United Kingdom

Guojing Luo China

Xueyan Wang China

Elena Ferrer-Picón Spain

Weigang Shu China

Antonio Soriano Spain

Raymond A. Isidro United States

Ryan J. Rebernick United States

Daisuke Koyama Japan

Hidetomo Himuro

107 ×0.7

IMMUN

201 ×1.4

ONCOL

136 ×1.2

116 ×1.2

GENET

15 ×0.3

SURGE

Citations per year, relative to Hidetomo Himuro Hidetomo Himuro (= 1×) peers Daisuke Koyama

Countries citing papers authored by Hidetomo Himuro

Since Specialization

Citations

This map shows the geographic impact of Hidetomo Himuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetomo Himuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetomo Himuro more than expected).

Fields of papers citing papers by Hidetomo Himuro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetomo Himuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetomo Himuro. The network helps show where Hidetomo Himuro may publish in the future.

Co-authorship network of co-authors of Hidetomo Himuro

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetomo Himuro. A scholar is included among the top collaborators of Hidetomo Himuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetomo Himuro. Hidetomo Himuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mano, Yasunobu, Yuka Igarashi, KEISUKE KOMORI, et al.. (2025). Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer. Frontiers in Immunology. 16. 1521278–1521278.

Wei, Feifei, Hiroyuki Takeda, Koichi Azuma, et al.. (2025). Machine learning–based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors. Frontiers in Immunology. 16. 1666030–1666030.

Kouro, Taku, Daisuke Hoshino, Yasunobu Mano, et al.. (2025). Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence. Frontiers in Immunology. 16. 1502607–1502607. 1 indexed citations

Wei, Feifei, Taku Kouro, Yuko Nakamura, et al.. (2024). Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation. Computational and Structural Biotechnology Journal. 23. 859–869. 6 indexed citations

Kouro, Taku, Yasunobu Mano, Rika Kasajima, et al.. (2024). Novel chimeric antigen receptor‐expressing T cells targeting the malignant mesothelioma‐specific antigen sialylated HEG1. International Journal of Cancer. 154(10). 1828–1841. 5 indexed citations

Nakahara, Yoshiro, Taku Kouro, Satoru Motoyama, et al.. (2024). Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors. Frontiers in Cell and Developmental Biology. 11. 1324898–1324898. 3 indexed citations

Kishida, Takeshi, Taku Kouro, Yuka Igarashi, et al.. (2024). MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors. International Journal of Clinical Oncology. 29(6). 832–839. 5 indexed citations

Sekihara, Kazumasa, Hidetomo Himuro, Soji Toda, et al.. (2024). Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer. Biomedicines. 12(6). 1286–1286. 5 indexed citations

Himuro, Hidetomo, Yoshiro Nakahara, Yuka Igarashi, et al.. (2023). Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors. Cancer Immunology Immunotherapy. 72(8). 2829–2840. 21 indexed citations

10.

Shibata, Yosuke, Takeshi Kishida, Taku Kouro, et al.. (2023). Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma. Frontiers in Pharmacology. 14. 1269935–1269935. 3 indexed citations

11.

Kouro, Taku, Hidetomo Himuro, & Tetsuro Sasada. (2022). Exhaustion of CAR T cells: potential causes and solutions. Journal of Translational Medicine. 20(1). 239–239. 80 indexed citations

12.

Sekihara, Kazumasa, Hidetomo Himuro, Nao Saito, et al.. (2022). Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures. Cancer Cell International. 22(1). 391–391. 9 indexed citations

13.

Nakahara, Yoshiro, Takaji Matsutani, Yuka Igarashi, et al.. (2021). Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody. Cancer Immunology Immunotherapy. 70(10). 2881–2892. 17 indexed citations

14.

Himuro, Hidetomo, et al.. (2020). Imaging features in patients with SAPHO/CRMO: a pictorial review. Japanese Journal of Radiology. 38(7). 622–629. 18 indexed citations

15.

Himuro, Hidetomo. (2017). The Effect of Ozone on Colonic Epithelial Cells. The Kurume Medical Journal. 64(4). 75–81. 7 indexed citations

16.

Mizoguchi, Atsushi, et al.. (2017). Clinical importance of IL-22 cascade in IBD. Journal of Gastroenterology. 53(4). 465–474. 172 indexed citations

17.

Suefuji, Hiroaki, Etsuyo Ogo, Hiroshi Eto, et al.. (2017). PV-0190: The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy. Radiotherapy and Oncology. 123. S97–S98.

18.

Mizoguchi, Atsushi, et al.. (2015). Genetically engineered mouse models for studying inflammatory bowel disease. The Journal of Pathology. 238(2). 205–219. 36 indexed citations

19.

Himuro, Hidetomo, et al.. (1977). A case of intracranial osteochondroma (author's transl).. PubMed. 5(10). 1079–83. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact